Patent · US Active

Substituted benzimidazoles and benzopyrazoles as CCR(4) antagonists

US8685959B2 · kind B2 · utility

2Cited by

0References

45Claims

0Family size

Assignee

CHEMOCENTRYX, INC. · US

Inventors

Manmohan Reddy Leleti · Sunnyvale, US
Yandong Li · San Jose, US
Venkat Reddy Mali · Cupertino, US
Jay P. Powers · Pacifica, US
Ju Yang · Palo Alto, US

Key dates

Filing date	Nov 30, 2012
Grant date	Apr 1, 2014
Priority date	—
Expiry date	Nov 30, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D405/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Benzimidazole, benzopyrazole and benzotriazole compounds are provided which bind to CCR(4) and are useful for the treatment of diseases such as allergic diseases, autoimmune diseases, graft rejection and cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.